Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Jordan Belfort: Illegal Psychedelic Cured my Addiction and Opiate Cravings

PSYCH NEWS Editor | Curator -
"Wolf of Wall Street" Jordan Belfort is crediting his recovery from addiction and withdrawal to ibogaine, a psychedelic treatment currently illegal in...
View Post

Psyched Wellness ‘Calm’ Now Available at Locations in the United States.

PSYCH STOCK NEWS Editor | Curator -
Psyched Wellness Lists Calm at All Erewhon Market Locations in the United States Toronto, Ontario--(Newsfile Corp. - September 7,...
View Post

Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)

CLINICS Editor | Curator -
Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out...
View Post

Amanita Muscaria in a Vape!

Featured Editor | Curator -
Vaping amanita mushrooms? You heard it right! The new Happy Daze Amanita Muscaria...
View Post

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

INTERVIEW Editor | Curator -
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
View Post

Psychedelic Marketing Tips: Adrian Morrison

INTERVIEW Editor | Curator -
The Absolute Champion of Internet Advertising, Adrian Morrison, makes a believer out of Jordan, which is saying everything! Why can’t this be...
View Post

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

2023 Watch List Editor | Curator -
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.
View Post

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)

2023 Watch List Editor | Curator -
Above: Lamar Odom and Psychedelic Advocate Mike Zappy Zapolin. We’re Calling a Sector Bottom, and Psycheceutical (BWVI)...
View Post

Ketamine and Yale University

INTERVIEW Editor | Curator -
Depression is one of the most common and most debilitating mental health disorders, affecting some 17 million adults in the US. It...
View Post

Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research

CLINICAL TRIALS Editor | Curator -
John Hopkins Center for Psychedelic and Consciousness Research Johns Hopkins University academics just a got a boost in their funding thanks to...
View Post

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

2023 Watch List Editor | Curator -
After Dropping 94% From Post IPO high from $19.45, a loss of exceeding $3 billion and change, ATAI is in the early...
View Post

PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD

INTERVIEW Editor | Curator -
Psycheceutical ​​enters into agreement with iNGENū to conduct ​human ​clinical trials of NeuroDirect™ ketamine topical ​in Australia
View Post

The Kahner Global Cannabis & Psychedelics Investment Summit.

PSYCH NEWS Editor | Curator -
Kahner Global’s 8th annual Cannabis & Psychedelics Investment Summit  When:...
View Post
123...9Page 1 of 9

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Jordan Belfort: Illegal Psychedelic Cured my Addiction and Opiate Cravings

PSYCH NEWS Editor | Curator -
"Wolf of Wall Street" Jordan Belfort is crediting his recovery from addiction and withdrawal to ibogaine, a psychedelic treatment currently illegal in...

Psyched Wellness ‘Calm’ Now Available at Locations in the United States.

PSYCH STOCK NEWS Editor | Curator -
Psyched Wellness Lists Calm at All Erewhon Market Locations in the United States Toronto, Ontario--(Newsfile Corp. - September 7,...

Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)

CLINICS Editor | Curator -
Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.